A detailed history of Quantinno Capital Management LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Quantinno Capital Management LP holds 29,417 shares of FLGT stock, worth $664,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,417
Previous 14,937 96.94%
Holding current value
$664,235
Previous $252,000 131.75%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$16.86 - $21.81 $244,132 - $315,808
14,480 Added 96.94%
29,417 $584,000
Q1 2025

May 12, 2025

BUY
$15.28 - $18.95 $28,390 - $35,209
1,858 Added 14.21%
14,937 $252,000
Q4 2024

Feb 14, 2025

BUY
$16.71 - $22.68 $218,550 - $296,631
13,079 New
13,079 $241,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $683M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.